Online inquiry

IVTScrip™ mRNA-Human ANKHD1-EIF4EBP3, (Cap 0, 2-Thio-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK17289MR)

This product GTTS-WK17289MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 2-Thio-UTP. It ecodes the ANKHD1-EIF4EBP3 protein. This product can be used in Multilymphoid progenitor cell-related researches.
Specifications
Product type mRNA
Modified bases 2-Thio-UTP
5' Cap Cap 0
Species Human
RefSeq NM_020690.6
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 404734
UniProt ID H7C0V5
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKHD1-EIF4EBP3, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) (GTTS-WK17289MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK18880MR IVTScrip™ mRNA-Human AP2A2, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA AP2A2
GTTS-WK7813MR IVTScrip™ mRNA-Human AAGAB, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA AAGAB
GTTS-WK27585MR IVTScrip™ mRNA-Human ATP1B1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ATP1B1
GTTS-WK17397MR IVTScrip™ mRNA-Human APBA3, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA APBA3
GTTS-WK25773MR IVTScrip™ mRNA-Human ATP10B, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ATP10B
GTTS-WK16975MR IVTScrip™ mRNA-Human Androgen-binding protein, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA Androgen-binding protein
GTTS-WK14149MR IVTScrip™ mRNA-Human ABCC5, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ABCC5
GTTS-WK21879MR IVTScrip™ mRNA-Human ATP13A2, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ATP13A2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →